Immunology
What is a rheumatic disease?
More than 200 conditions are classified as rheumatic diseases, including rheumatoid arthritis, lupus and Sjögren’s disease. They tend to affect the joints and connective tissues, causing pain and swelling and impacting quality of life. Here’s what a doctor wants you to know about the different types, symptoms and risk factors—and how Johnson & Johnson is innovating new treatments.
“I couldn’t speak, walk or sit.” Inside a rare autoimmune disease that attacks the muscles
Elisa Glass was diagnosed with dermatomyositis, which causes severe muscle weakness throughout the body. Learn more about the disease and how Johnson & Johnson is working to develop a treatment to help Glass and other patients like her.
What is IL-23?
This pro-inflammatory protein is the target of potential Johnson & Johnson medications that could help treat autoimmune conditions such as psoriasis, inflammatory bowel disease and rheumatoid arthritis.
What it’s like when your baby has a rare blood disorder
A condition called fetal and neonatal alloimmune thrombocytopenia (FNAIT) can be deadly in newborns. That’s why Johnson & Johnson is passionate about developing a treatment for the disorder.
Advancing diversity: 3 healthcare experts share their career stories
The statistics are stark: People of color are vastly underrepresented in medical and scientific professions. But various programs—including ones sponsored by Johnson & Johnson—are working to help level the playing field.
“I had a condition that threatened my chances of having healthy children”
For Pregnancy and Infant Loss Awareness Month, learn how one woman advocated for herself and fought to complete her family after she was diagnosed with hemolytic disease of the fetus and newborn—and why Johnson & Johnson is committed to finding a better treatment for this rare and deadly blood disorder.
“I’m working to develop better treatments for children with devastating diseases”
A life-threatening condition that afflicts young cancer patients. A rare and painful form of pediatric arthritis. Learn about how Johnson & Johnson is innovating to use existing medications to help kids with these illnesses—and meet two women on the forefront of this game-changing work.
The quest to make neurodegenerative disease a thing of the past
Imagine reversing the course of conditions like Alzheimer’s or multiple sclerosis, in which cells of the central nervous system stop working or die. Researchers at Johnson & Johnson are hot on the trail of innovative solutions that may do just that, preventing often-debilitating symptoms along the way.
What it takes to truly diversify clinical trials
What do diseases like multiple myeloma and lupus have in common? They’re more prevalent in people of color—yet historically these patients have been left out of clinical research, often to dire health consequences. Learn how Johnson & Johnson is working to make the study of conditions like these more equitable.